# Sofie Biosciences completes acquisition of Zevacor Pharma

Sofie Biosciences completed the acquisition of Zevacor Pharma, forming a combined company called SOFIE. Zevacor Pharma operates 16 radiopharmacies and a contract manufacturing organization, serving over 425,000 patients annually.

- Type: Acquisition
- Announced: 2017-09-27
- Where: United States
- Status: completed
- Products: PET imaging compounds, radiopharmaceuticals, Neuraceq, NETSPOT, 11C-Choline, NaF
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sofie Biosciences](https://endata.com/companies/27179.md) (acquirer)
- [Zevacor Pharma](https://endata.com/companies/27180.md) (target)

## Sources

- [sofie.com](https://sofie.com/2017/09/27/acquisition-of-zevacor-pharma-complete/), 2017-09-27: "As SOFIE, we'll continue Zevacor Pharma's commitment to customers, while making significant improvements to prepare us for growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.